Results 101 to 110 of about 110,558 (326)

A Rare Case of Pseudomembranous Colitis Presenting with Pleural Effusion and Ascites with Literature Review

open access: yesCase Reports in Gastrointestinal Medicine, 2021
Clostridium difficile infection usually results from long-term and irregular antibiotic intake. The high-risk individuals for this infection include the patients undergoing chemotherapy due to malignancy, immunocompromised patients, and hospitalized ...
Hossain Salehi, Amir Mohammad Salehi
doaj   +1 more source

Assessment of the utility of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay [PDF]

open access: yes, 2015
The poor performance of toxin enzyme immunoassay (EIA) for laboratory testing for Clostridium difficile (C. difficile) infection (CDI) is well acknowledged. Guidelines published in recent years state that testing solely with EIA for detecting toxins A
Barbara, Christopher   +2 more
core   +1 more source

Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers [PDF]

open access: yesarXiv, 2018
Clostridium difficile infections (CDIs) affect patients in hospitals and in the community, but the relative importance of transmission in each setting is unknown. We developed a mathematical model of C. difficile transmission in a hospital and surrounding community that included infants, adults, and transmission from animal reservoirs.
arxiv  

Fluid fragmentation from hospital toilets [PDF]

open access: yesarXiv, 2013
Hospital-acquired infections represent significant health and financial burdens to society. Clostridium difficile (C. difficile) is a particularly challenging bacteria with the potential to cause severe diarrhea and death. One mode of transmission for C.
arxiv  

Navigation and control of outcomes in a generalized Lotka-Volterra model of the microbiome [PDF]

open access: yesarXiv, 2020
The generalized Lotka-Volterra (gLV) equations model the microbiome as a collection of interacting ecological species. Here we use a particular experimentally-derived gLV model of C. difficile infection (CDI) as a case study to generate methods that are applicable to generic gLV models.
arxiv  

Microbiome-derived bile acids contribute to elevated antigenic response and bone erosion in rheumatoid arthritis [PDF]

open access: yesarXiv, 2023
Rheumatoid arthritis (RA) is a chronic, disabling and incurable autoimmune disease. It has been widely recognized that gut microbial dysbiosis is an important contributor to the pathogenesis of RA, although distinct alterations in microbiota have been associated with this disease.
arxiv  

Serum metabolic and microbial profiling yields insights into promoting effect of tryptophan‐related metabolites for health longevity in centenarians

open access: yesiMeta, EarlyView.
Schematic representation of the design. Tryptophan metabolism is enriched in serum metabolites and gut microbiota of centenarians, potentially contributing to healthy longevity. A key tryptophan metabolite 5‐methoxyindoleacetic acid (5‐MIAA) is linked to the Christensenellaceae R‐7 group and exhibits effects of delaying cell senescence, promoting ...
Xiaorou Qiu   +16 more
wiley   +1 more source

Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy

open access: yesCase Reports in Obstetrics and Gynecology, 2016
Background. Diarrhea is a common problem in ovarian cancer patients undergoing chemotherapy and Clostridium difficile infection has been identified as a cause.
Valerie A. Allen   +2 more
doaj   +1 more source

Evidence for antibiotic induced Clostridium perfringens diarrhoea [PDF]

open access: yes, 2001
Clostridium difficile is a well documented cause of antibiotic associated diarrhoea in hospitalised patients, but may account for only approximately 20% of all cases.
Modi, N., Wilcox, M.H.
core   +1 more source

Bezlotoxumab for prevention of recurrent Clostridium difficile infection in patients at increased risk for recurrence [PDF]

open access: yes, 2018
Background: Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B indicated to prevent C. difficile infection (CDI) recurrence (rCDI) in adults at high risk for rCDI. This post hoc analysis of pooled monocolonal antibodies for
Dorr, Mary Beth   +12 more
core   +2 more sources

Home - About - Disclaimer - Privacy